{{Chembox
| ImageFile = Nipradilol.svg
| ImageSize = 200px
| ImageAlt = 
| IUPACName = [8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate
| OtherNames = 
|Section1={{Chembox Identifiers
| CASNo = 81486-22-8
| PubChem = 72006
| InChI=1S/C15H22N2O6/c1-10(2)16-7-12(18)8-21-14-5-3-4-11-6-13(23-17(19)20)9-22-15(11)14/h3-5,10,12-13,16,18H,6-9H2,1-2H3
| InChIKey= OMCPLEZZPVJJIS-UHFFFAOYSA-N
| SMILES = CC(C)NCC(COC1=CC=CC2=C1OCC(C2)O[N+](=O)[O-])O
| ChemSpiderID = 65005}}
|Section2={{Chembox Properties
| C=15 | H=22 | N=2 | O=6
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt = }}
}}

'''Nipradilol''' is a [[beta blocker]] and [[nitric oxide donor]].<ref>{{cite journal|pmid=21966188|year=2011|last1=Inoue|first1=K|last2=Kei Noguchi|first2=K|last3=Masumoto|first3=M|last4=Wakakura|first4=G|title=Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma|volume=5|pages=1211â€“6|doi=10.2147/OPTH.S23233|pmc=3180485|journal=Clinical ophthalmology (Auckland, N.Z.)}}</ref>

==References==
{{Reflist|2}}


{{Adrenergics}}
{{Nitric oxide signaling}}

[[Category:Beta blockers]]
[[Category:Nitrate esters]]


{{organic-compound-stub}}
{{pharma-stub}}